English By VOA News Share on Facebook Print this page
German pharmaceutical giant Bayer announced Monday it will help a smaller German biomedical company, CureVac, produce its experimental COVID-19 vaccine, the latest drug maker to offer up manufacturing capacity as supplies fall behind demand worldwide.
At a virtual news conference hosted in Berlin Monday by Health Minister Jens Spahn, Bayer’s pharmaceutical chief, Stefan Oelrich, said the company expects to produce 160 million doses of CureVac s experimental vaccine, which is currently in late-stage testing, in 2022.
Bayer and CureVac reached an agreement last month to work together on a vaccine. Oelrich said Bayer has experience and capacity to expand CureVac s production capacity.
Meet German Chancellor Angela Merkel s potential successors
Raymond Colitt and Iain Rogers, Bloomberg
Jan. 14, 2021
FacebookTwitterEmail
German national flags fly at the Reichstag building in Berlin on Oct. 8, 2020.Bloomberg photo by Krisztian Bocsi.
Germany s political future will start to take shape when 1,001 delegates from Angela Merkel s Christian Democratic Union pick a new leader at a virtual congress on Saturday.
The winner of a tight three-way race will be in prime position to run as the conservative bloc s chancellor candidate, but there are two other contenders who might do better with voters. The messy process will set up a tense few months for Germany s strongest political group.
Corona: Spahn mahnt Bürger – RKI meldet rund 12 000 neue Fälle mz-web.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mz-web.de Daily Mail and Mail on Sunday newspapers.
Das Rennen um den CDU-Vorsitz spitzt sich zu wienerzeitung.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wienerzeitung.at Daily Mail and Mail on Sunday newspapers.